Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3.

    Lundsgaard D, Holm TL, Hornum L, Markholst H.

    Diabetes. 2005 Apr;54(4):1040-7.PMID: 15793242 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.

    Holm TL, Lundsgaard D, Markholst H.

    Scand J Immunol. 2006 Jul;64(1):17-29.PMID: 16784487 [PubMed - indexed for MEDLINE]Related articles

    3.

    A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.

    Hillebrands JL, Whalen B, Visser JT, Koning J, Bishop KD, Leif J, Rozing J, Mordes JP, Greiner DL, Rossini AA.

    J Immunol. 2006 Dec 1;177(11):7820-32.PMID: 17114453 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.

    Ly D, Mi QS, Hussain S, Delovitch TL.

    J Immunol. 2006 Sep 15;177(6):3695-704.PMID: 16951329 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.

    Peng Y, Laouar Y, Li MO, Green EA, Flavell RA.

    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4572-7. Epub 2004 Mar 18.PMID: 15070759 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes.

    Arndt T, Wedekind D, Weiss H, Tiedge M, Lenzen S, Hedrich HJ, Jörns A.

    Diabetologia. 2009 Jul;52(7):1381-90. Epub 2009 Apr 15.PMID: 19367386 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.

    Every AL, Kramer DR, Mannering SI, Lew AM, Harrison LC.

    J Immunol. 2006 Apr 15;176(8):4608-15.PMID: 16585551 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.

    Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M.

    Diabetes. 2007 Mar;56(3):604-12.PMID: 17327427 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

    Exp Hematol. 2007 Mar;35(3):416-25.PMID: 17309822 [PubMed - indexed for MEDLINE]Related articles

    12.

    The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.

    Szanya V, Ermann J, Taylor C, Holness C, Fathman CG.

    J Immunol. 2002 Sep 1;169(5):2461-5.PMID: 12193715 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo.

    Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR, Blessing M.

    Int Immunol. 2004 Sep;16(9):1241-9. Epub 2004 Jul 12.PMID: 15249539 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.

    Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J.

    J Immunol. 2006 Jul 1;177(1):209-15.PMID: 16785516 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.

    Diabetes. 2008 Jan;57(1):113-23. Epub 2007 Oct 10.PMID: 17928397 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats.

    Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S.

    J Immunol. 2005 Apr 1;174(7):4081-9.PMID: 15778366 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.

    Brode S, Raine T, Zaccone P, Cooke A.

    J Immunol. 2006 Nov 15;177(10):6603-12.PMID: 17082572 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

    Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R.

    J Exp Med. 2005 Apr 18;201(8):1333-46.PMID: 15837817 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.

    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5. Epub 2004 Aug 30.PMID: 15340148 [PubMed - indexed for MEDLINE]Related articlesFree article